U

Universitätsmedizin Mainz - Zentrum für Kardiologie - Studienzentrum

Research site

Location

Langenbeckstr. 1, Mainz, Rhineland-Palatinate, Germany

Website

https://www.unimedizin-mainz.de/kardiologie/index.html

Site insights

Top conditions

Top treatments

Semaglutide

Edoxaban

Clopidogrel

Ralinepag

Dabigatran

Prasugrel

Acetylsalicylic acid

Apixaban

Rivaroxaban

Ticagrelor

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Active trials

4 of 17 total trials

A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension

Study ROR-PH-303, ADVANCE EXTENSION, is an open-label extension (OLE) study for participants with WHO Group 1 PAH who have participated in another Ph...

Invitation-only

Hypertension

Familial Primary Pulmonary Hypertension

Drug: Ralinepag

Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial

To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System in patients with degenerative mitral regurgitation...

Active, not recruiting

Degenerative Mitral Valve Disease

Functional Mitral Regurgitation

Device: Edwards PASCAL System

Device: Abbott Mitraclip System

Renal Denervation to Treat Heart Failure With Preserved Ejection Fraction (UNLOAD-HFpEF)

Heart failure with preserved ejection fraction has a high mortality, which is contrasted by a total absence of therapy options besides symptomatic di...

Enrolling

Hypertension, Renal

Heart Failure With Preserved Ejection Fraction

Procedure: Sham

Procedure: Renal Denervation

ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation

This study is conducted to see if ziltivekimab reduces the risk of having cardiovascular events (for example heart attack and stroke) in people with...

Active, not recruiting

Chronic Kidney Disease

Inflammation

Drug: Placebo (Ziltivekimab B)

Drug: Placebo (Ziltivekimab C)